Long acting injectable aripiprazole for bipolar one patients has been shown to significantly reduce the risk of a recurrence of a mood episode in a 52 week placebo controlled clinical trial. Poor adherence to treatment is a significant problem in patients with bipolar disorder, putting patients at increased risk of recurrence of mood episodes, hospitalization, and suicide. One other study …
TMS Guidelines
[Published: June 26, 2016 | Updated: May 14, 2026] In the April 2016 edition of Brain Stimulation, the Clinical TMS Society published expert consensus guidelines on the use of TMS. This review of the literature summarizes current evidence as well as areas of ongoing uncertainty regarding the use of TMS in the treatment of depression. The process of developing the …